My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 100

    1.

    A denileukin diftitox (Ontak) associated retinopathy?

    Ruddle JB, Harper CA, Hönemann D, Seymour JF, Prince HM.

    Br J Ophthalmol. 2006 Aug;90(8):1070-1. No abstract available. PMID: 16854841 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Denileukin diftitox and vision loss.

    Ruddle JB, Prince HM.

    Leuk Lymphoma. 2007 Apr;48(4):655-6. No abstract available. PMID: 17454621 [PubMed - indexed for MEDLINE]Related articles

    3.

    Vision loss following denileukin diftitox treatment: a case report of possible posterior ischemic optic neuropathy.

    Park M, Liu GT, Piltz-Seymour J, Wisda CL, Rook AH, Junkins-Hopkins JM, Nasta SD, Kim EJ.

    Leuk Lymphoma. 2007 Apr;48(4):808-11. No abstract available. PMID: 17454642 [PubMed - indexed for MEDLINE]Related articles

    4.

    Toxic epidermal necrolysis associated with denileukin diftitox (DAB389IL-2) administration in a patient with follicular large cell lymphoma.

    Polder K, Wang C, Duvic M, Diwan AH, Parks D, Jankov A, Walker PL, Tong AT, Bull J, Dang NH.

    Leuk Lymphoma. 2005 Dec;46(12):1807-11.PMID: 16263585 [PubMed - indexed for MEDLINE]Related articles

    5.

    Optimizing denileukin diftitox (Ontak) therapy.

    Duvic M, Talpur R.

    Future Oncol. 2008 Aug;4(4):457-69. Review.PMID: 18684057 [PubMed - indexed for MEDLINE]Related articles

    6.

    Thyrotoxicosis after denileukin diftitox therapy in patients with mycosis fungoides.

    Ghori F, Polder KD, Pinter-Brown LC, Hoff AO, Gagel RF, Sherman SI, Duvic M.

    J Clin Endocrinol Metab. 2006 Jun;91(6):2205-8. Epub 2006 Apr 4.PMID: 16595600 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Phase II clinical studies of denileukin diftitox diphtheria toxin fusion protein in patients with previously treated chronic lymphocytic leukemia.

    Frankel AE, Surendranathan A, Black JH, White A, Ganjoo K, Cripe LD.

    Cancer. 2006 May 15;106(10):2158-64.PMID: 16586495 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Denilieukin diftitox vision loss is not posterior ischemic optic neuropathy.

    Lubow M, Grzybowski DM, Awad H.

    Leuk Lymphoma. 2008 Feb;49(2):370-1; author reply 372. No abstract available. PMID: 18231931 [PubMed - indexed for MEDLINE]Related articles

    9.

    A complete and durable response to denileukin diftitox in a patient with mycosis fungoides.

    Carretero-Margolis CD, Fivenson DP.

    J Am Acad Dermatol. 2003 Feb;48(2):275-6.PMID: 12582402 [PubMed - indexed for MEDLINE]Related articles

    10.

    Denileukin diftitox as novel targeted therapy in non-Hodgkin's lymphoma.

    Walker PL, Dang NH.

    Clin J Oncol Nurs. 2004 Apr;8(2):169-74. Review.PMID: 15108419 [PubMed - indexed for MEDLINE]Related articles

    11.

    Phase II study of denileukin diftitox for relapsed/refractory B-Cell non-Hodgkin's lymphoma.

    Dang NH, Hagemeister FB, Pro B, McLaughlin P, Romaguera JE, Jones D, Samuels B, Samaniego F, Younes A, Wang M, Goy A, Rodriguez MA, Walker PL, Arredondo Y, Tong AT, Fayad L.

    J Clin Oncol. 2004 Oct 15;22(20):4095-102. Epub 2004 Sep 7.PMID: 15353540 [PubMed - indexed for MEDLINE]Related articles

    12.

    Durable complete remission of mycosis fungoides following erythroderma induced by denileukin diftitox.

    Kazin R, Bujanauskas P, Vonderheid EC.

    J Am Acad Dermatol. 2008 Feb;58(2 Suppl):S31-2. No abstract available. PMID: 18191695 [PubMed - indexed for MEDLINE]Related articles

    13.

    Phase II trial of denileukin diftitox for relapsed/refractory T-cell non-Hodgkin lymphoma.

    Dang NH, Pro B, Hagemeister FB, Samaniego F, Jones D, Samuels BI, Rodriguez MA, Goy A, Romaguera JE, McLaughlin P, Tong AT, Turturro F, Walker PL, Fayad L.

    Br J Haematol. 2007 Feb;136(3):439-47.PMID: 17233846 [PubMed - indexed for MEDLINE]Related articles

    14.

    Inability of a fusion protein of IL-2 and diphtheria toxin (Denileukin Diftitox, DAB389IL-2, ONTAK) to eliminate regulatory T lymphocytes in patients with melanoma.

    Attia P, Maker AV, Haworth LR, Rogers-Freezer L, Rosenberg SA.

    J Immunother. 2005 Nov-Dec;28(6):582-92.PMID: 16224276 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Lethal vascular leak syndrome after denileukin diftitox administration to a patient with cutaneous gamma/delta T-cell lymphoma and occult cirrhosis.

    Avarbock AB, Loren AW, Park JY, Junkins-Hopkins JM, Choi J, Litzky LA, Rook AH.

    Am J Hematol. 2008 Jul;83(7):593-5.PMID: 18335564 [PubMed - indexed for MEDLINE]Related articles

    16.

    Biological correlates of acute hypersensitivity events with DAB(389)IL-2 (denileukin diftitox, ONTAK) in cutaneous T-cell lymphoma: decreased frequency and severity with steroid premedication.

    Foss FM, Bacha P, Osann KE, Demierre MF, Bell T, Kuzel T.

    Clin Lymphoma. 2001 Mar;1(4):298-302.PMID: 11707845 [PubMed - indexed for MEDLINE]Related articles

    17.

    A phase-1 trial of bexarotene and denileukin diftitox in patients with relapsed or refractory cutaneous T-cell lymphoma.

    Foss F, Demierre MF, DiVenuti G.

    Blood. 2005 Jul 15;106(2):454-7. Epub 2005 Apr 5.PMID: 15811959 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Clinical experience with denileukin diftitox (ONTAK).

    Foss F.

    Semin Oncol. 2006 Feb;33(1 Suppl 3):S11-6. Review.PMID: 16516670 [PubMed - indexed for MEDLINE]Related articles

    19.

    CD25 expression is correlated with histological grade and response to denileukin diftitox in cutaneous T-cell lymphoma.

    Talpur R, Jones DM, Alencar AJ, Apisarnthanarax N, Herne KL, Yang Y, Duvic M.

    J Invest Dermatol. 2006 Mar;126(3):575-83.PMID: 16410787 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Quality-of-life improvements in cutaneous T-cell lymphoma patients treated with denileukin diftitox (ONTAK).

    Duvic M, Kuzel TM, Olsen EA, Martin AG, Foss FM, Kim YH, Heald PW, Bacha P, Nichols J, Liepa A.

    Clin Lymphoma. 2002 Mar;2(4):222-8.PMID: 11970761 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity